MTA3 and breast carcinoma: Taken together, these studies suggest a mutual functional repression between Notch1 and ERα signaling in breast cancer EMT, where ERα-responsive genes (e.g., MTA3) would repress the expression of EMT-transcription factors laying downstream the Notch pathway.